SMT201900481T1 - Composizione combinata - Google Patents

Composizione combinata

Info

Publication number
SMT201900481T1
SMT201900481T1 SM20190481T SMT201900481T SMT201900481T1 SM T201900481 T1 SMT201900481 T1 SM T201900481T1 SM 20190481 T SM20190481 T SM 20190481T SM T201900481 T SMT201900481 T SM T201900481T SM T201900481 T1 SMT201900481 T1 SM T201900481T1
Authority
SM
San Marino
Prior art keywords
combination composition
composition
combination
Prior art date
Application number
SM20190481T
Other languages
English (en)
Italian (it)
Inventor
Hartley Campbell Atkinson
Original Assignee
Aft Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46024668&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201900481(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aft Pharmaceuticals Ltd filed Critical Aft Pharmaceuticals Ltd
Publication of SMT201900481T1 publication Critical patent/SMT201900481T1/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SM20190481T 2010-11-04 2011-10-26 Composizione combinata SMT201900481T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ58901110 2010-11-04
PCT/NZ2011/000226 WO2012060719A1 (en) 2010-11-04 2011-10-26 A combination composition
EP11838295.1A EP2635269B1 (en) 2010-11-04 2011-10-26 A combination composition

Publications (1)

Publication Number Publication Date
SMT201900481T1 true SMT201900481T1 (it) 2019-11-13

Family

ID=46024668

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20190481T SMT201900481T1 (it) 2010-11-04 2011-10-26 Composizione combinata

Country Status (28)

Country Link
US (6) US20130225685A1 (https=)
EP (1) EP2635269B1 (https=)
JP (2) JP2013541583A (https=)
KR (1) KR101900520B1 (https=)
CN (2) CN103298464A (https=)
AU (1) AU2011324137B2 (https=)
BR (1) BR112013010829B8 (https=)
CA (1) CA2814057C (https=)
CL (1) CL2013001250A1 (https=)
CO (1) CO6771406A2 (https=)
CY (1) CY1123398T1 (https=)
DK (1) DK2635269T3 (https=)
ES (1) ES2742373T3 (https=)
HR (1) HRP20191489T1 (https=)
HU (1) HUE045442T2 (https=)
LT (1) LT2635269T (https=)
MX (2) MX2013005113A (https=)
MY (1) MY160572A (https=)
NZ (1) NZ609727A (https=)
PH (2) PH12013500689A1 (https=)
PL (1) PL2635269T3 (https=)
PT (1) PT2635269T (https=)
RS (1) RS59258B1 (https=)
RU (2) RU2707089C2 (https=)
SG (1) SG189319A1 (https=)
SI (1) SI2635269T1 (https=)
SM (1) SMT201900481T1 (https=)
WO (1) WO2012060719A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130225685A1 (en) 2010-11-04 2013-08-29 Aft Pharmaceuticals Limited Combination composition
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
WO2016008546A1 (en) 2014-07-18 2016-01-21 Everbright Pharmaceuticals S.A.R.L. Aqueous formulation comprising paracetamol and ibuprofen
KR20170066549A (ko) * 2014-10-06 2017-06-14 큠버랜드 파마슈티컬즈 인코포레이티드 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여
WO2018192664A1 (en) 2017-04-20 2018-10-25 Hyloris Developments Sa METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF
CN114681324B (zh) * 2017-07-10 2024-05-03 盖尔凯普科技有限公司 双释放剂型胶囊及其制备方法、装置和系统
US11197830B2 (en) 2019-02-27 2021-12-14 Aft Pharmaceuticals Limited Pharmaceutical composition containing acetaminophen and ibuprofen
US11568752B2 (en) * 2020-01-28 2023-01-31 David Clark Company Incorporated Gateway retrieval alert device for aircraft pushback operations
WO2023281089A2 (en) 2021-07-08 2023-01-12 Krka, D.D., Novo Mesto Pharmaceutical composition comprising naproxen and paracetamol
IL324832A (en) 2023-06-02 2026-01-01 Ioulia Tseti Pharmaceutical composition comprising ibuprofen
GR1010809B (el) * 2023-09-13 2024-10-25 Ιουλια Τσετη Υδατικο διαλυμα ιβουπροφαινης παρακεταμολης για χρηση σε ενδοφλεβια χορηγηση
GR1010769B (el) * 2023-07-27 2024-09-18 Ιουλια Κλεωνος Τσετη Υδατικο διαλυμα ιβουπροφαινης για χρηση σε ενδοφλεβια χορηγηση

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic
DE60114249T2 (de) * 2001-11-02 2006-05-18 Cumberland Pharmaceuticals Inc., Nashville Pharmazeutische zusammensetzung mit 2-(4-isobutylphenyl) propionsäure
CN1758904A (zh) * 2003-03-21 2006-04-12 麦克内尔-Ppc股份有限公司 非甾体抗炎药物的给药方案
ATE543491T1 (de) * 2004-07-07 2012-02-15 Aft Pharmaceuticals Ltd Kombinationspräparat enthaltend ibuprofen und paracetamol
KR20060072839A (ko) * 2004-12-23 2006-06-28 김경태 아세트아미노펜과 이부프로펜을 이용하여 통증조절과 해열작용을 하는 주사제
US7934627B2 (en) * 2005-10-13 2011-05-03 Alcoa Inc. Apparatus and method for high pressure extrusion with molten aluminum
CA2666582C (en) * 2006-10-20 2014-09-09 Mcneil-Ppc, Inc. Acetaminophen / ibuprofen combinations
WO2008079818A2 (en) * 2006-12-21 2008-07-03 Soluprin Pharmaceuticals, Inc. Intravenous administration of water soluble analgesic formulations
US20090264530A1 (en) * 2008-04-16 2009-10-22 Nickell Robert P Combined nsaid and acetaminophen formulation and method
US20110166234A1 (en) * 2008-10-14 2011-07-07 Atkinson Hartley Campbell Medicinal product and treatment
KR20140014350A (ko) * 2009-03-12 2014-02-06 큠버랜드 파마슈티컬즈 인코포레이티드 정맥 내 투여용 이부프로펜의 투여
SG186388A1 (en) * 2010-07-07 2013-01-30 Aft Pharmaceuticals Ltd A combination composition comprising ibuprofen and paracetamol
US20130225685A1 (en) 2010-11-04 2013-08-29 Aft Pharmaceuticals Limited Combination composition
KR20170066549A (ko) * 2014-10-06 2017-06-14 큠버랜드 파마슈티컬즈 인코포레이티드 통증 치료를 위한 이부프로펜과 아세트아미노펜의 공동 정맥 투여

Also Published As

Publication number Publication date
BR112013010829A2 (pt) 2016-08-16
US20190029982A1 (en) 2019-01-31
KR101900520B1 (ko) 2018-09-19
RU2015103107A (ru) 2015-06-20
SI2635269T1 (sl) 2019-10-30
US20250134839A1 (en) 2025-05-01
EP2635269A1 (en) 2013-09-11
CN107519159A (zh) 2017-12-29
US20160235695A1 (en) 2016-08-18
RU2015103107A3 (https=) 2018-08-20
CL2013001250A1 (es) 2013-08-30
BR112013010829B8 (pt) 2022-01-04
RU2707089C2 (ru) 2019-11-22
PT2635269T (pt) 2019-09-04
DK2635269T3 (da) 2019-08-26
CO6771406A2 (es) 2013-10-15
LT2635269T (lt) 2019-09-10
US11896567B2 (en) 2024-02-13
CY1123398T1 (el) 2021-10-29
NZ609727A (en) 2015-07-31
RU2013123646A (ru) 2014-12-10
HUE045442T2 (hu) 2019-12-30
MX367209B (es) 2019-07-22
JP2017132791A (ja) 2017-08-03
AU2011324137A1 (en) 2013-05-02
US12220392B2 (en) 2025-02-11
HRP20191489T1 (hr) 2019-11-15
JP2013541583A (ja) 2013-11-14
MY160572A (en) 2017-03-15
PH12013500689A1 (en) 2013-05-27
WO2012060719A1 (en) 2012-05-10
AU2011324137B2 (en) 2015-05-07
MX2013005113A (es) 2013-06-03
RS59258B1 (sr) 2019-10-31
EP2635269B1 (en) 2019-05-22
JP6353577B2 (ja) 2018-07-04
BR112013010829B1 (pt) 2021-12-21
PL2635269T3 (pl) 2019-11-29
US20230000805A1 (en) 2023-01-05
CN103298464A (zh) 2013-09-11
SG189319A1 (en) 2013-05-31
KR20140025314A (ko) 2014-03-04
US11446266B2 (en) 2022-09-20
US20130225685A1 (en) 2013-08-29
ES2742373T3 (es) 2020-02-14
CA2814057C (en) 2022-02-01
US20240207210A1 (en) 2024-06-27
PH12021550804A1 (en) 2022-02-14
CA2814057A1 (en) 2012-05-10
EP2635269A4 (en) 2014-09-17

Similar Documents

Publication Publication Date Title
GB201002983D0 (en) Nutritinal composition
GB201006699D0 (en) Composition
GB201021186D0 (en) Composition
EP2611352A4 (en) DISHWASHER
SMT201900481T1 (it) Composizione combinata
GB201006178D0 (en) Composition
GB201021269D0 (en) Composition
GB201017048D0 (en) Composition
ZA201302505B (en) A sunscreen composition
GB201007327D0 (en) A fireseal
GB201016970D0 (en) Composition
ZA201303199B (en) Herbicicdal composition
SI2625258T1 (sl) Sestavek za čiščenje polimerov
GB201019988D0 (en) Composition
KR101209432B9 (ko) 복근재활기구
GB201007531D0 (en) Composition
GB201006214D0 (en) Composition
GB201005927D0 (en) Improved composition
GB201006204D0 (en) Composition
GB201004717D0 (en) Composition
GB201002966D0 (en) A bedchair
GB201014967D0 (en) Composition
GB201010657D0 (en) Composition
ZA201300756B (en) A novel biocide composition
PL2534235T3 (pl) Kompozycja